Modulation of airway responsiveness by the airway epithelium in humans: Putative mechanisms

Clinical and Experimental Allergy

Volumn 26, Issue 11, 1996, Pages 1236-1242

  Hulsmann, A R ^a   De Jongste, J C ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ENDOTHELIUM DERIVED RELAXING FACTOR; LEUKOTRIENE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TACHYKININ;

ASTHMA; ELECTRON MICROSCOPY; ENDOTHELIUM; HUMAN; METABOLISM; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW;

BRONCHIAL HYPERREACTIVITY; CELL MEMBRANE PERMEABILITY; EPITHELIUM; HUMANS; MUSCLE, SMOOTH; RESPIRATORY SYSTEM;

EID: 0029860541     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00519.x     Document Type: Review

References (53)

1. Montefort S, Herbert CA, Robinson C, Holgate ST. The bronchial epithelium as a target for inflammatory attack in asthma. Clin Exp Allergy 1992; 22:511-20.
2. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, Kay AB. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989; 140:1745-53.
3. Ohashi Y, Motojima S, Fukuda T, Makino S. Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis 1992; 145:1469-76.
4. Bousquet J, Chanez P, Vignola AM, Lacoste JY, Michel F-B. Eosinophilic inflammation in asthma. Am J Respir Crit Care Med 1994; 150:S33-8.
5. Coyle AJ, Uchida D, Ackerman SJ, Mitzner W, Irvin CG. Role of cationic proteins in the airway hyperresponsiveness due to airways inflammation. Am J Respir Crit Care Med 1994; 150:S63-71.
6. Persson CGA, Anderson M, Greiff L et al. Review: airway permeability. Clin Exp Allergy 1995; 23:807-14.
7. Farmer SG, Hay DWP. Airway epithelial modulation of smooth muscle function: the evidence for epithelium-derived inhibitory factor. In: Farmer SG, Hay, DWP, eds. The airway epithelium: physiology, pathophysiology and pharmacology. New York: Marcel Dekker Inc. 1991:437-84.
8. Lilly CM, Drazen JM, Shore SA. Minireview: peptidase modulation of airway effects of neuropeptides. Proc Soc Exp Biol Med 1993; 203:388-404.
9. Munakata M, Mitzner W. The protective role of airway epithelium. In: Farmer SG, Hay DWP, eds. The airway epithelium: physiology, pathophysiology and pharmacology. New York: Marcel Dekker Inc. 1991:545-64.
10. Joos GF, Germonpré PR, Kips JC, Peleman RA, Pauwels RA. Sensory neuropeptides and the human lower airways: present state and future directions. Eur Respir J 1994; 7:1161-71.
11. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-42.
12. Nijkamp FP, Van der Linde HJ, Folkerts G. Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro. Am Rev Respir Dis 1993; 148:727-34.
13. Nijkamp FP, Folkerts G. Review: nitric oxide and bronchial reactivity. Clin Exp Allergy 1994; 24:905-14.
14. Holtzman MJ. Arachidonic acid metabolism in airway epithelial cells. Annu Rev Physiol 1992; 54:303-29.
15. Coleman RA, Sheldrick RLG. Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP receptors. Br J Pharmacol 1989; 96:688-92.
16. Coleman RA, Smith WL, Narumiya S. Classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994; 46:205-29.
17. Hay DWP, Torphy TJ, Undem BJ. Cysteinyl leukotrienes in asthma: old mediators up to new tricks. Trends Pharmacol Sci 1995; 16:304-9.
18. 2 and thromboxane prostanoid receptors. Am J Respir Crit Care Med 1994; 150:1012-8.
19. Gaston B, Drazen JM, Loscalzo J, Stamler JS. State of the art: the biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149:538-51.
20. Zhao W, Guenard H. Effect of nitric oxide on in vitro responsiveness of bovine bronchus and pulmonary vessels. Eur Respir J 1995; 8:755-61.
21. Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic vasoconstriction without causing systemic vasodilation. Anesthesiology 1993; 78:427-35.
22. Högman M, Frostell CG, Hedenström H, Hedenstierna G. Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis 1993; 148:1474-8.
23. Koga Y, Satoh S, Sodeyama N et al. Role of cholinesterase in airway epithelium-mediated inhibition of acetylcholine-induced contraction of guinea-pig isolated trachea. Eur J Pharmacol 1992; 220:141-6.
24. Okayama M, Yamauchi K, Sekizawa K et al. Localization of histamine N-methyltransferase messenger RNA in human nasal mucosa. J Allergy Clin Immunol 1995; 95:96-102.
25. Heffner JE, Repine JE. Pulmonary strategies of antioxidant defence. Am Rev Respir Dis 1989; 140:531-4.
26. Avissar N, Finkelstein JN, Horowitz S et al. Extracellular glutathione peroxidase in human lung epithelial lining fluid and in lung cells. Am J Physiol 1996; 270:L173-82.
27. Raeburn D, Webber SE. Review: proinflammatory potential of the airway epithelium in bronchial asthma. Eur Respir J 1994; 7:2226-33.
28. Thompson AB, Robbins RA, Romberger DJ, Sisson JH, Spurzem JR, Teschler H, Rennard SI. Immunological functions of the pulmonary epithelium. Eur Respir J 1995; 8:127-49.
29. Borson DB. Roles of neutral endopeptidase in airways. Am J Physiol 1991; 260:L212-25.
30. Baraniuk JN, Ohkubo K, Kwon OJ et al. Localization of neutral endopeptidase (NEP) mRNA in human bronchi. Eur Respir J 1995; 8:1458-64.
31. Cheung D, Timmers MC, Zwinderman AH et al. Neutral endopeptidase activity and airway hyperresponsiveness to neurokinin A in asthmatic subjects in vivo. Am Rev Respir Dis 1993; 148:1467-73.
32. Joos GF, Kips JC, Pauwels RA. Editorial: a role for neutral endopeptidase in asthma? Clin Exp Allergy 1994; 24:91-3.
33. Schneeberger EE, Lynch RD. Structure, function, and regulation of cellular tight junctions. Am J Physiol 1992; 262:L647-61.
34. Lewis SA, Berg JR, Kleine TJ. Modulation of epithelial permeability by extracellular macromolecules. Physiol Rev 1995; 75:561-89.
35. 99mTc-DTPA in asthma. Am Rev Respir Dis 1989; 139:1139-43.
36. Hulsmann AR, Raatgeep HC, Den Hollander JC et al. Oxidative damage produces hyperresponsiveness of human peripheral airways. Am J Respir Crit Care Med 1994; 149:519-25.
37. Hulsmann AR, Raatgeep HC, Den Hollander JC et al. Permeability of human peripheral airways increases after exposure to hydrogen peroxide and poly-L-arginine. Am J Respir Crit Care Med 1996; 153:841-6.
38. Lozewicz S, Wells C, Gomez E et al. Morphological integrity of the bronchial epithelium in mild asthma. Thorax 1990; 45:12-5.
39. Coyle AJ, Ackerman SJ, Burch R, Proud D, Irvin CG. Human eosinophil-granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation. J Clin Invest 1995; 95:1735-40.
40. Busse WW. Viral infections in humans. Am J Respir Crit Care Med 1995; 151:1675-7.
41. Folkerts G, Van der Linde HJ, Nijkamp FP. Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide. J Clin Invest 1995; 95:26-30.
42. Barnes PJ, Baraniuk JN, Belvisi MG. Neuropeptides in the respiratory tract. Part 1. Am Rev Respir Dis 1991; 144:1187-98.
43. Lou YP. Regulation of neuropeptide release from pulmonary capsaicin-sensitive afferents in relation to bronchoconstriction. Acta Physiol Scand Suppl. 1993; 612:1-8.
44. Maggi CA. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog Neurobiol 1995; 48:1-98.
45. Martling C-R. Sensory nerves containing tachykinins and CGRP in the lower airways. Functional implications for bronchoconstriction, vasodilatation and protein extravasation. Acta Physiol Scand 1987; 563:S1-57.
46. 1 binding sites between human and guinea pig lung. Br J Pharmacol 1994; 113:1407-15.
47. Nieber K, Baumgarten CR, Rathsack R et al. Substance P and β-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol 1992; 90:646-52.
48. Tomaki M, Ichinose M, Miura M et al. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 1995; 151:613-7.
49. Ichinose M, Nakajima N, Takahashi T et al. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonists. Lancet 1992; 340:1248-51.
50. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991; 43:143-201.
51. Hulsmann AR, Raatgeep HR, Zijlstra FJ, Saxena PR, De Jongste JC. Capsaicin induces bronchoconstriction and tachykinin release in human isolated airways, submitted.
52. Brown RH, Zerhouni EA, Mitzner W. Airway edema potentiates airway reactivity. J Appl Physiol 1995; 79:1242-8.
53. Regnard J, Beji M, Dessanges JF et al. Is tracheobronchial vasodilation a component of bronchial hyperresponsiveness? Eur Respir J 1990 3:678-85s.